<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00176410</url>
  </required_header>
  <id_info>
    <org_study_id>Leipzig aortic valve study</org_study_id>
    <nct_id>NCT00176410</nct_id>
  </id_info>
  <brief_title>Statin Therapy in Asymptomatic Aortic Stenosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <brief_summary>
    <textblock>
      There is evidence that the degenerative changes leading to aortic stenosis are caused by a&#xD;
      chronic inflammatory process. Furthermore the development of aortic stenosis is partially&#xD;
      dependent on typical cardiovascular risk factors. An inflammatory process as well as those&#xD;
      risk factors are amenable for medical therapy. As such the use of statins (HMG CoA reductase&#xD;
      inhibitors) would be an appealing concept to reduce both those risks for development of&#xD;
      aortic stenosis. Aim of this study is to evaluate the usefulness of statin therapy on the&#xD;
      progression of aortic stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective, double-blind, placebo-controlled, two-armed clinical trial&#xD;
      trial to test the influence of statin therapy on the progression of calcified aortic stenosis&#xD;
      in patients with asymptomatic mild to moderate aortic stenosis. After completion of all&#xD;
      baseline investigations patients will be randomly assigned to the verum group (fluvastatin&#xD;
      group) or to the control group (placebo group). Patients in the verum group will receive&#xD;
      fluvastatin in a starting dose of 40 mg per day. The dose should be increased up to 80 mg per&#xD;
      day. The treatment should be continued until the study end (24 months). Follow up&#xD;
      investigations will be performed after 6, 12, and 18 months. After 24 months the final&#xD;
      investigations will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2003</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">September 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression of calcified aortic stenosis measured by:</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Transthoracic echocardiography (P max/ mean; V max; AVA)</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Catheterization (peak to peak gradient, LV-function, compliance)</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of cardiovascular events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluvastatin</intervention_name>
    <description>40mg fluvastatin daily</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥ 21 years&#xD;
&#xD;
          2. Mild to moderate aortic stenosis&#xD;
&#xD;
          3. No symptoms caused by aortic stenosis&#xD;
&#xD;
          4. Written informed consent to participate in the study&#xD;
&#xD;
          5. Aortic valve leaflet thickening with reduced systolic opening&#xD;
&#xD;
          6. Reduced aortic valve area &gt; 0,8 cm2 and &lt; 1,5 cm2&#xD;
&#xD;
          7. Maximum aortic jet velocity at rest &gt; 2,5 m/s&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Symptoms caused by aortic stenosis&#xD;
&#xD;
          2. Aortic valve area &lt; 0,7 cm2&#xD;
&#xD;
          3. Severe aortic regurgitation&#xD;
&#xD;
          4. Reduced left ventricular ejection fraction (&lt; 50%)&#xD;
&#xD;
          5. Any valve disease with indication for surgery&#xD;
&#xD;
          6. Coronary artery disease&#xD;
&#xD;
          7. Therapy refractory arterial hypertension&#xD;
&#xD;
          8. Comorbid noncardiac diseases or other reasons which make a regular follow-up&#xD;
             impossible&#xD;
&#xD;
          9. Other indication for treatment with statins&#xD;
&#xD;
         10. Women of childbearing potential not using the contraception method(s) specified in&#xD;
             this study (specify), as well as women who are breastfeeding&#xD;
&#xD;
         11. Known sensitivity to study drug(s) or class of study drug(s)&#xD;
&#xD;
         12. Patients with severe medical condition(s) that in the view of the investigator&#xD;
             prohibits participation in the study (specify as required)&#xD;
&#xD;
         13. Use of any other investigational agent in the last 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Schuler, Professor</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Claudia Walther, MD</last_name>
    <phone>xx49-341-8651428</phone>
    <email>waltherc@medizin.uni-leipzig.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Leipzig - Heart Center</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Walther, MD</last_name>
      <phone>xx49-341-8651428</phone>
      <email>waltherc@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Claudia A Walther, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2006</verification_date>
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>January 13, 2010</last_update_submitted>
  <last_update_submitted_qc>January 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Claudia Walther</name_title>
    <organization>University of Leipzig, Department of Cardiology</organization>
  </responsible_party>
  <keyword>aortic valve stenosis</keyword>
  <keyword>statin therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

